JP2025515995A5 - - Google Patents
Info
- Publication number
- JP2025515995A5 JP2025515995A5 JP2024560356A JP2024560356A JP2025515995A5 JP 2025515995 A5 JP2025515995 A5 JP 2025515995A5 JP 2024560356 A JP2024560356 A JP 2024560356A JP 2024560356 A JP2024560356 A JP 2024560356A JP 2025515995 A5 JP2025515995 A5 JP 2025515995A5
- Authority
- JP
- Japan
- Prior art keywords
- cell according
- acid sequence
- domain
- nucleic acid
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263331758P | 2022-04-15 | 2022-04-15 | |
| US63/331,758 | 2022-04-15 | ||
| US202263341995P | 2022-05-13 | 2022-05-13 | |
| US63/341,995 | 2022-05-13 | ||
| PCT/US2023/065710 WO2023201288A1 (en) | 2022-04-15 | 2023-04-13 | Cd70 binding car-t cells comprising cd33 binding t-cell engaging antibody molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515995A JP2025515995A (ja) | 2025-05-23 |
| JP2025515995A5 true JP2025515995A5 (enExample) | 2026-04-21 |
Family
ID=88330369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560356A Pending JP2025515995A (ja) | 2022-04-15 | 2023-04-13 | Ｃｄ３３結合ｔ細胞エンゲージ抗体分子を含むｃｄ７０結合ｃａｒ－ｔ細胞 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250249037A1 (enExample) |
| EP (1) | EP4507706A4 (enExample) |
| JP (1) | JP2025515995A (enExample) |
| CN (1) | CN119365202A (enExample) |
| AU (1) | AU2023254840A1 (enExample) |
| CA (1) | CA3248652A1 (enExample) |
| WO (1) | WO2023201288A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3568466A4 (en) | 2017-01-10 | 2020-07-15 | The General Hospital Corporation | TARGETED T CELLS WITH CYTOTOXICITY TO IMMUNOSUPPRESSIVE CELLS |
| US12378297B2 (en) | 2017-04-14 | 2025-08-05 | The General Hospital Corporation | Chimeric antigen receptor T cells targeting the tumor microenvironment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10875919B2 (en) * | 2016-04-26 | 2020-12-29 | Alector Llc | Chimeric receptors and methods of use thereof |
| CA3048648A1 (en) * | 2017-01-10 | 2018-07-19 | The General Hospital Corporation | T cells expressing a chimeric antigen receptor |
| US20190153096A1 (en) * | 2017-10-02 | 2019-05-23 | Covagen Ag | Cd3/cd33 bispecific binding molecules |
| MX2020012028A (es) * | 2018-05-11 | 2021-03-29 | Crispr Therapeutics Ag | Metodos y composiciones para tratar el cancer. |
| EP4031150A4 (en) * | 2019-09-16 | 2023-11-01 | The General Hospital Corporation | CD70-DIRECTED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS AND USES THEREOF |
-
2023
- 2023-04-13 AU AU2023254840A patent/AU2023254840A1/en active Pending
- 2023-04-13 CN CN202380047510.1A patent/CN119365202A/zh active Pending
- 2023-04-13 EP EP23789144.5A patent/EP4507706A4/en active Pending
- 2023-04-13 WO PCT/US2023/065710 patent/WO2023201288A1/en not_active Ceased
- 2023-04-13 CA CA3248652A patent/CA3248652A1/en active Pending
- 2023-04-13 US US18/856,583 patent/US20250249037A1/en active Pending
- 2023-04-13 JP JP2024560356A patent/JP2025515995A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7419434B2 (ja) | 新規のポリペプチド | |
| US12281176B2 (en) | Binding molecules for BCMA and CD3 | |
| JP7492561B2 (ja) | ヒト化ｂｃｍａ抗体およびｂｃｍａ－ｃａｒ－ｔ細胞 | |
| US12421292B2 (en) | Anti-DLL3 chimeric antigen receptors and uses thereof | |
| JP2022504822A5 (enExample) | ||
| JP2022542543A5 (enExample) | ||
| JP7749319B2 (ja) | Ｃｔｌａ－４変異型免疫調節タンパク質およびそれらの使用 | |
| JP7527641B2 (ja) | スイッチ分子及びスイッチャブルキメラ抗原受容体 | |
| JP2025515995A5 (enExample) | ||
| IL318835A (en) | IL-18 fusion proteins and methods for producing IL-18 | |
| CA3201518A1 (en) | Bi-functional molecules | |
| US20240294673A1 (en) | Recombinant proteinaceous binding molecules | |
| JP2024504162A5 (enExample) | ||
| JP2024504728A5 (enExample) | ||
| JP2022553292A5 (enExample) | ||
| TW202221015A (zh) | 單一及雙靶定配體誘導之t細胞銜接體組合物 | |
| WO2023217062A1 (zh) | 一种嵌合抗原受体及其应用 | |
| CN114075287B (zh) | 人源化bcma抗体和bcma-car-t细胞 | |
| EP4566619A1 (en) | Targeting modules against cd19 and cd20 for use in a method for stimulating a reversed chimeric antigen receptor-mediated immune response in a mammal | |
| WO2025103456A1 (en) | Gprc5d-binding moieties, chimeric antigen receptors and uses thereof | |
| AU2024393901A1 (en) | Targeting modules against cd19 and cd20 for use in a method for stimulating a reversed | |
| HK40125822A (en) | Targeting modules against cd19 and cd20 for use in a method for stimulating a reversed chimeric antigen receptor-mediated immune response in a mammal | |
| JP2025524457A (ja) | 哺乳動物におけるキメラ抗原受容体介在性の免疫応答を刺激するための方法において使用するためのｃｄ１２３に対する標的化モジュール | |
| HK40073076A (en) | Anti-cd137 antibodies | |
| AU2012327200B2 (en) | Binding molecules for BCMA and CD3 |